Literature DB >> 19648123

Mutation in IFT80 in a fetus with the phenotype of Verma-Naumoff provides molecular evidence for Jeune-Verma-Naumoff dysplasia spectrum.

Denise P Cavalcanti1, Celine Huber, Kim-Hanh Le Quan Sang, Geneviève Baujat, Felicity Collins, Anne-Lise Delezoide, Nathalie Dagoneau, Martine Le Merrer, Jelena Martinovic, Marcos Fernando S Mello, Michel Vekemans, Arnold Munnich, Valerie Cormier-Daire.   

Abstract

BACKGROUND: The lethal group of short-rib polydactyly (SRP) includes type I (Saldino-Noonan; MIM 263530), type II (Majewski; MIM 263520), type III (Verma-Naumoff; MIM 263510) and type IV (Beemer-Langer; MIM 269860). Jeune and Ellis-van Creveld dysplasias also used to be classified in the SRP group. Recently, mutations in a gene encoding a protein involved in intraflagellar transport, IFT80, have been identified in 3/39 patients with Jeune dysplasia but no extraskeletal manifestation.
METHODS: Because of clinical and radiological similarities between Jeune dysplasia and the other lethal types of SRP, the authors decided to investigate IFT80 in a cohort of fetuses with the lethal forms of SRP (Majewski, Verma-Naumoff and Beemer-Langer) and antenatally diagnosed cases of Jeune dysplasia. Fifteen fetuses were identified. A double-molecular approach was adopted. For consanguineous families and for those with recurrent sibs, a haplotype analysis around the gene locus was first performed, and, for the others, all the coding exons of IFT80 were directly sequenced.
RESULTS: Using the haplotype approach for two families, the authors excluded the IFT80 region as a candidate for them. Direct sequencing of IFT80 in the other 13 cases showed a G-to-C transversion in exon 8 (G241R) in only one SRP case closely related to the type III phenotype.
CONCLUSIONS: The findings show that mutations in IFT80 can also be responsible for a lethal form of SRP and provide the molecular basis for the Jeune-Verma-Naumoff dysplasia spectrum.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648123     DOI: 10.1136/jmg.2009.069468

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  32 in total

1.  Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutations.

Authors:  Isabelle Perrault; Sophie Saunier; Sylvain Hanein; Emilie Filhol; Albane A Bizet; Felicity Collins; Mustafa A M Salih; Sylvie Gerber; Nathalie Delphin; Karine Bigot; Christophe Orssaud; Eduardo Silva; Véronique Baudouin; Machteld M Oud; Nora Shannon; Martine Le Merrer; Olivier Roche; Christine Pietrement; Jamal Goumid; Clarisse Baumann; Christine Bole-Feysot; Patrick Nitschke; Mohammed Zahrate; Philip Beales; Heleen H Arts; Arnold Munnich; Josseline Kaplan; Corinne Antignac; Valérie Cormier-Daire; Jean-Michel Rozet
Journal:  Am J Hum Genet       Date:  2012-04-12       Impact factor: 11.025

2.  Mutations in Traf3ip1 reveal defects in ciliogenesis, embryonic development, and altered cell size regulation.

Authors:  Nicolas F Berbari; Nicholas W Kin; Neeraj Sharma; Edward J Michaud; Robert A Kesterson; Bradley K Yoder
Journal:  Dev Biol       Date:  2011-09-16       Impact factor: 3.582

3.  The intraflagellar transport protein IFT80 is required for cilia formation and osteogenesis.

Authors:  Shuying Yang; Changdong Wang
Journal:  Bone       Date:  2012-07-04       Impact factor: 4.398

4.  Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19.

Authors:  Cecilie Bredrup; Sophie Saunier; Machteld M Oud; Torunn Fiskerstrand; Alexander Hoischen; Damien Brackman; Sabine M Leh; Marit Midtbø; Emilie Filhol; Christine Bole-Feysot; Patrick Nitschké; Christian Gilissen; Olav H Haugen; Jan-Stephan F Sanders; Irene Stolte-Dijkstra; Dorus A Mans; Eric J Steenbergen; Ben C J Hamel; Marie Matignon; Rolph Pfundt; Cécile Jeanpierre; Helge Boman; Eyvind Rødahl; Joris A Veltman; Per M Knappskog; Nine V A M Knoers; Ronald Roepman; Heleen H Arts
Journal:  Am J Hum Genet       Date:  2011-10-20       Impact factor: 11.025

5.  An Ift80 mouse model of short rib polydactyly syndromes shows defects in hedgehog signalling without loss or malformation of cilia.

Authors:  Suzanne Rix; Amelie Calmont; Peter J Scambler; Philip L Beales
Journal:  Hum Mol Genet       Date:  2011-01-12       Impact factor: 6.150

6.  IFT52 mutations destabilize anterograde complex assembly, disrupt ciliogenesis and result in short rib polydactyly syndrome.

Authors:  Wenjuan Zhang; S Paige Taylor; Lisette Nevarez; Ralph S Lachman; Deborah A Nickerson; Michael Bamshad; Deborah Krakow; Daniel H Cohn
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

7.  An inactivating mutation in intestinal cell kinase, ICK, impairs hedgehog signalling and causes short rib-polydactyly syndrome.

Authors:  S Paige Taylor; Michaela Kunova Bosakova; Miroslav Varecha; Lukas Balek; Tomas Barta; Lukas Trantirek; Iva Jelinkova; Ivan Duran; Iva Vesela; Kimberly N Forlenza; Jorge H Martin; Ales Hampl; Michael Bamshad; Deborah Nickerson; Margie L Jaworski; Jieun Song; Hyuk Wan Ko; Daniel H Cohn; Deborah Krakow; Pavel Krejci
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

Review 8.  Function and regulation of primary cilia and intraflagellar transport proteins in the skeleton.

Authors:  Xue Yuan; Rosa A Serra; Shuying Yang
Journal:  Ann N Y Acad Sci       Date:  2014-06-24       Impact factor: 5.691

9.  IFT80 is essential for chondrocyte differentiation by regulating Hedgehog and Wnt signaling pathways.

Authors:  Changdong Wang; Xue Yuan; Shuying Yang
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

10.  Autosomal recessive IFT57 hypomorphic mutation cause ciliary transport defect in unclassified oral-facial-digital syndrome with short stature and brachymesophalangia.

Authors:  J Thevenon; L Duplomb; S Phadke; T Eguether; A Saunier; M Avila; V Carmignac; A-L Bruel; J St-Onge; Y Duffourd; G J Pazour; B Franco; T Attie-Bitach; A Masurel-Paulet; J-B Rivière; V Cormier-Daire; C Philippe; L Faivre; C Thauvin-Robinet
Journal:  Clin Genet       Date:  2016-04-29       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.